Preterm Birth Risk Up for Women With Low Vitamin D

Share this content:
Preterm Birth Risk Up for Women With Low Vitamin D
Preterm Birth Risk Up for Women With Low Vitamin D

MONDAY, Jan. 12, 2015 (HealthDay News) -- Women who have low blood levels of vitamin D during pregnancy are more likely to give birth prematurely, new research suggests. The study was published online Jan. 7 in Obstetrics & Gynecology.

Lisa Bodnar, Ph.D., associate professor of epidemiology and obstetrics and gynecology at the University of Pittsburgh, and colleagues looked at 2,123 women who didn't give birth early, and 1,126 who delivered preterm. All of the women included in the research had given birth to single infants between 1999 and 2010. The researchers grouped the women as having serum 25-hydroxyvitamin D of less than 50 nmol/L, 50 to 74.9 nmol/L, and 75 nmol/L or above.

The researchers found that women with the lowest levels of vitamin D were about 1.5 times as likely to deliver early compared to those with the highest levels. Before adjusting for other preterm birth risks, the researchers found that 11.3 percent of the mothers in the lowest vitamin D level group delivered before 37 weeks. About 9 percent of mothers (8.6 percent) in the middle group delivered early and 7.3 percent of those in the highest level group delivered early. When the researchers adjusted the data to account for other preterm birth risk factors, they saw a similar association between lower vitamin D levels and preterm birth.

"Mothers who were deficient in vitamin D in early parts of pregnancy were more likely to deliver early, preterm, than women who did not have vitamin D deficiency," Bodnar told HealthDay. Vitamin D may provide benefit by helping to reduce bacterial infection in the placenta, which can trigger an early delivery, she said.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »